Podcasts about Medicine

In this episode,  Dr. Derek Wheeler, COO of Lurie Children's Hospital and Professor of Pediatrics at Northwestern University Feinberg School of Medicine, shares insights on driving improvements in patient safety, staff well-being, and family experience while navigating financial headwinds and strengthening the hospital's long-standing reputation for excellence.

Episode 68 - Heal It by Opening Up Possibilities - Dr. Bernie Siegel, legendary healer and author of Love, Medicine and Miracles, speaks about the profound connection between emotional, spiritual and physical healing. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

When a new kidney could save your life, every minute counts. When Jazmin Evans discovered she could have received a kidney four years earlier, she was shocked. When she found out the delay was due to a racially biased testing process, she tried to warn others. This is a story from the archives. This originally aired on December 19, 2024. None of the dates, titles or other references from that time have been changed. In this episode: Jazmin Evans, Kidney Transplant Patient, PhD Student of Africology at Temple University Episode credits: This episode was produced by Manahil Naveed and Amy Walters, with Veronique Eshaya, Shraddha Joshi, and our host Malika Bilal. It was edited by Alexandra Locke. Our sound designer is Alex Roldan. Our video editors are Hisham Abu Salah and Mohannad Al-Melhem. Alexandra Locke is The Take’s executive producer. Ney Alvarez is Al Jazeera’s head of audio. We’ll be back tomorrow.

Send us a textIn this episode of The Incubator Podcast, Dr. Guilherme Sant'Anna, Professor of Pediatrics at McGill University, joins Ben and Daphna to discuss his team's work on implementing an early bubble CPAP protocol in the delivery room. Although CPAP has long been considered standard practice for preterm infants, Dr. Sant'Anna explains why intubation rates remain high in the most immature babies and how his group sought to change this pattern.The conversation reviews the background of the protocol, which began at McGill in 2014, and the cultural shift required to adopt bubble CPAP as the default approach. Dr. Sant'Anna describes the importance of multidisciplinary training, technical details such as proper prong sizing, fixation, humidification, and suctioning, as well as the challenges of sustaining practice change over a decade.The results of this initiative are striking: lower rates of delivery room intubation, reduced severe BPD, and improvements in outcomes particularly for infants born before 28 weeks. Dr. Sant'Anna also reflects on lessons learned, the global implications of bubble CPAP in resource-limited settings, and the importance of sharing knowledge to improve care everywhere.This episode highlights how attention to detail, persistence, and team culture can transform neonatal respiratory care.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

For weight loss, complete avoidance of ultra-processed foods outperforms mere “healthy diet” comprising minimally-processed items; Research fraud undermines anti-dementia drug pipeline; Comprehensive lifestyle modification program scores against cognitive decline; Women's brains especially vulnerable to Omega-3 deficiencies; Bible says “Lame shall walk again” and 21st century science may soon bring about this miracle; Breakthroughs in rheumatoid arthritis treatment.

RFK Jr. issues sharpest ultimatum yet to medical schools: “Start teaching nutrition now or face penalties!” Fast-food outlets continue to abound in teaching hospitals; Once serious causes of flank pain are ruled out, patients are often left to fend for themselves; Potatoes don't increase risk of diabetes—unless you eat French fries; Deep-frying in seed oils can yield harmful byproducts—but so, too, when you substitute with lard; As doctors get more aggressive treating blood pressure, how to minimize medication side effects; New study shows beetroot juice can lower BP by 7 points.

Jason M. Raidbard, MPA, FACMPE, Executive Administrator of the Department of Ophthalmology and Visual Sciences at UChicago Medicine and Biological Sciences, shares insights on opportunities for growth and development within healthcare organizations. He discusses financial strategies, alleviating burdens for staff, and adapting to new rule changes, while emphasizing the importance of recognizing organizational weaknesses to drive meaningful improvements.

Pastor Alex Sagot

Sinan Gölhan, Founder and CEO of GelTech is helping scientists develop life-saving hydrogel treatments faster through automation. From cancer-fighting gels to battlefield-ready biomaterials, Sinan's journey fuses deep technical insight with an intensely personal mission.In this episode, we talk about why hydrogels, the “Jell-O of medicine”, are so important in modern biotech, and how Sinan's frustration with repetitive lab work led him to build robotic systems to accelerate testing. He shares hard-won lessons from early fundraising, what labs get wrong about automation, and how he turned rejection into resilience. We also dive into the world of battlefield bleeding control, nanotech-based drug delivery, and the future of AI-driven materials science.Timestamps:[00:00:18] What Are Hydrogels and Why They Matter[00:02:30] A Personal Mission: Cancer, Family and Science[00:04:45] From Lab Frustration to Robotic Innovation[00:06:33] Fundraising Real Talk: Angels, Grants, and Grit[00:10:42] How GelTech's Platform Actually Works[00:13:33] Hydrogels in Your Fridge and in the OR[00:14:54] Why Lab Automation Isn't a Luxury[00:16:23] The Coming Wave of Smart Materials[00:20:11] Battlefield Nanotech: Bleeding Control with Gels[00:27:25] Advice to Founders: Obsession, Vision and PersistenceGet in touch with Sinan - https://www.linkedin.com/in/sinan-g%C3%B6lhan-a49691b6/ Learn more about Exagen - https://www.geltechlabs.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

Pullback is breaking for the summer, but we have a bonus episode for our lovely listeners! Kristen is joined by Gregor Wolbring to discuss ways the climate movement could become more inclusive. Gregor is a professor at the University of Calgary's Cumming School of Medicine and part of his impressive academic background includes sustainability, disability, and ability studies. Learn more about the Bristol climate and disability action plan Gregor recommends following A Change in the Climate, a creative contribution to the University of Exeter's Sensing Climate project researching climate change and disability, led by Dr Sarah Bell and funded via a Philip Leverhulme Prize in Geography. Dr. Sara Bell, mentioned in the episode, is working on the project Sensing Climate, which is placing disabled people at the forefront of the climate crisis. We also encourage listeners to check out The Canadian Disability and Climate Change Network and Strategy Project.

In this episode, we welcome Dr. Joseph Holland, MD, MSHA, who recently matched at the Harvard Combined Dermatology Residency Training Program. Dr. Holland, a graduate of the University of Louisville School of Medicine, shares his path to dermatology, strategies for navigating the residency application process, and key lessons learned along the way. Outside of medicine, he is well known for his engaging TikTok presence, including his viral “match” video that has reached nearly 3 million views on his page, @dermdocbestie. Whether you're a medical student, future dermatologist, or simply curious about the residency journey, this episode offers inspiration, practical advice, and insight into the match process. We hope you enjoy!Connect with Dr.Holland:TikTok: https://www.tiktok.com/@dermdocbestieInsta: https://www.instagram.com/drjosephhollandEmail: josephhollandmd@gmail.com---DIGA Instagram: ⁠@derminterest⁠Today's Host: Shan Francis---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠---Music: "District Four" Kevin MacLeod (⁠⁠⁠⁠⁠⁠⁠incompetech.com⁠⁠⁠⁠⁠⁠⁠) Licensed under Creative Commons:By Attribution 4.0 License:⁠⁠⁠⁠⁠⁠⁠ http://creativecommons.org/licenses/by/4.0

Arrenca una nova temporada a la pista. Compromesos amb els nostres balladors, portem noms coneguts, descobertes i molt ball per al dia u de la 25-26. 01 Madonna - "Frozen (Widescreen Mix and Drums)" 02 Propaganda - Purveyor of pleasure (Moby remix)" 03 Mof - "Languague game" 04 Delivery - "Deadlines (Jonah Swilley remix)" 05 Years Of Denial - "We are the party" 06 Landscape - "Einstein a go-go (Einstein on the Floor 2023 remix)" 07 Saint Etienne - "Take me to the pilot" 08 Gilligan Moss - "Who loves you" 09 Darco - "We we we" 10 The XX - "Crystalised (Bletter Maccabi edit)" 11 Avaion x Rani - "Slowly" 12 Malugy - "Chiggy chiggy feat. In

The First Principles of The Limping ChildIn this episode we seek to break down a common paediatric presentation into the essentials, primarily covering a systematic approach to differentiating the causative pathologies. Join us as we limp towards a diagnosis.=== Other Links ===Check out our notion document on this topic:https://www.notion.so/1pm/37-The-Limping-Child-261ef1d0b55f80bf84e1eb1b3a86b736 Check out our website 1pm .wiki for the Notion document, free Anki flashcards, and podcast episodes.Instagram: https://www.instagram.com/firstprinciplesofmedicine/Recorded May 2025. Hosts: Abdulla Ellagta, Norman Luyt, Danial KhongProduced by Abdulla EllagtaIf you have any ideas or feedback, comment on this Notion document, or shoot us an email at hello@1pm.wiki© First Principles of Medicine 2025

See omnystudio.com/listener for privacy information.

Jackie Dallas was only a year from finishing her residency in pathology when she decided to leave medicine, move to California, and pursue acting. Through hardworking and perverance, she has appeared on many hit shows, including playing "Jen Woo" (science teacher Mr. Clarke's girlfriend) in Season 1 of "Stranger Things." You can see her now in The Hunting Wives, which is currently the No. 1 show on Netflix. You'll also get to know how she's using her current platform and her training as a medical doctor to help countless women understand the importance of pelvic health and to get help if needed.

In this episode of the My DPC Story Podcast, Dr. Maryal Concepcion hosts Dr. Holly Shen and Dr. Aaron Morganstein to discuss physician entrepreneurship and the power of collaboration in Direct Primary Care (DPC), locum tenens, and direct contracting. The trio introduces the upcoming Rise Up Physician Summit—a virtual event designed to empower physicians with tools and education to take control of their medical careers, improve financial independence, and explore non-traditional clinical paths. Listeners will hear real stories about leaving traditional employment, gaining professional and personal autonomy, building supportive physician communities, and balancing clinical work with passion projects. The episode covers actionable advice for both new and experienced doctors considering DPC, locums, or direct contracting, while highlighting the crucial role of mentorship and peer support in navigating alternative career models in medicine. Register for the summit at flexmedstaff.com/RiseUp to access transformative content and connect with a community reimagining modern medical practice. Early Bird Registration ends 9/15/25.Join Hint's BOOTCAMP today! hint.com/bootcamp.Download Elation's FREE Startup Checklist HERE. Get a practice audit and 80 FREE hours of VA work for your DPC with Cool Blue VA! Check out the latest Cool Blue VA Episode HERE!Schedule a demo with Cerbo today!Spruce Health: All-In-One Patient Co Hint Clinical: Run your dream practice with Hint's DPC softwareA-S Medication Solutions: medication management made simple for DPC. Learn more about JumpStart DPC Solutions: Marketing solutions modeled after DPCSupport the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

UT Health San Antonio Speech-Language Pathology program graduate students are helping local kids at risk for developing a language disorder through a program called LAUNCH. Angela Kennedy, SLP-D, CCC-SLP, is the director of clinical education and an assistant professor for the Speech-Language Pathology program in the Department of Communication Sciences and Disorders.

Episode 75 You Are the Servant: Redefining Medicine Through Indigenous Wisdom ft. Dr. Lonnie Nelson On this episode host Raj Sundar sits down with Dr. Lonnie Nelson, a clinical psychologist and member of the Cherokee Indians, to explore the importance of centering Native communities in healthcare research and practice. We learn about how Lonnie's personal experiences with family health challenges shaped his professional journey, and how he reframes common clinical approaches to focus on culture, self-determination, and relational trust. They dive deep into the role of "culture as medicine," uncovering how traditional practices and genuine human connection can foster healing far beyond what Western medicine often recognizes. They also discuss Lonnie's work addressing health disparities, brain health research in urban Native elders, and the need to move away from transactional, role-based healthcare toward true person-centered care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr. Fatima Daoud is a board-certified obstetrician/gynecologist and the first OBGYN guest on Doctor's Inn. Dr. Daoud is a clinical assistant professor at Stony Brook University and a widely recognized voice in women's health—featured on Buzzfeed, Cosmopolitan, The Washington Post, Teen Vogue, and more for her advocacy in debunking misinformation and promoting accessible, equitable care.In this episode, we dive into the hidden inequities faced by women of color in pregnancy care, how unconscious biases shape medical training and patient encounters, and the historical roots of discrimination within medical specialties. Dr. Daoud also shares her insights on balancing faith and cultural humility in women's health, navigating the challenges of residency and rotations, and empowering patients with accurate, evidence-based education. Whether you're a medical student, practicing clinician, or simply curious about women's health, this conversation sheds light on the path toward a more inclusive and just future in medicine.Follow Dr. Daoud on Instagram @doctordaoud to learn more about her work, media features, and upcoming projects.If you want to support Doctor's Inn, here are some easy ways:1. Leave a rating! We welcome all feedback!2. Visit our website at www.doctorsinnpodcast.com to gain access to in-depth resources and our YouTube channel at Doctor's Inn Podcast to watch short engaging animated videos3. Follow our socials @doctorsinnpodcast

Send us a textWhat if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outperforms us.Episode Highlights:[00:02:49] Neuropathology image analysis (Boston VA & BU) – Why traditional semiquantitative scoring often fails, and how AI-based density quantification reveals more subtle pathology in CTE.[00:13:16] Chronic kidney changes with AI (Mayo Clinic, Cambridge, Emory, Geneva) – A 20-class AI model trained on 20,500 annotations, showing how multiclass segmentation outperforms human guesswork in renal pathology.[00:21:09] Digital hematology review (University of Pennsylvania) – Current hurdles in AI for blood and bone marrow evaluation: regulatory oversight, data standardization, and resistance to change.[00:25:52] AI in cytology review (Journal of Cytopathology) – From BD FocalPoint to deep learning: two decades of digital cytology, stagnation, and why adoption still lags despite proven benefits.[00:32:09] Neuropathology goes digital – Where digital neuropathology is already routine (Ohio State, Mayo Clinic, Leeds, Granada) and why this specialty is crucial for pushing adoption.[00:34:19] Personal note – Why I believe learning, sharing, and experimenting with AI tools now will shape the way we practice pathology tomorrow.Resources from this EpisodeComparison of quantitative strategies in neuropathologic image analysis – Boston VA / BU Brain Bank study.Multiclass AI model for chronic kidney changes – Mayo Clinic, Cambridge, Emory, Georgia Tech, Geneva collaboration.Review: Digital hematology in the AI era – International Journal of Laboratory Hematology.Review: AI and machine learning in cytology – Journal of the American Society of Cytopathology.Digital Pathology 101 (by me, Dr. Aleksandra Zuraw) – Free PDF & Amazon print edition.Pathology AI Makeover Course – Practical training for AI in pathology workflows.Support the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

Hawaii's healthcare system will always have room for physicians, nurses, and volunteers. At Kaiser Permanente Hawaii, they offer ways for those with interests in caregiving and medicine to discover which pathway best suits the individual. "Hawaii Matters" talks story with Dr. Serena Lo, Jackie Fernando, and JABSOM third-year medical student Brent Shimoda, on how their paths crossed to further evolve this innovative concept into reality. They each share how the program helped them pay-it-forward, in and out of the hospital.In "Hawaii Matters, Hana Hou", an excerpt from June 2025 on HIOSH's Whitleblower Protection Program with supervisor Lovelle Koike. A listen on "what 'retaliation' or 'adverse actions' mean in relation to HIOSH filings. Kathy With a K is your host. Image (left to right): Serena Lo, MD, Geriatric Medicine Physician, Kaiser Permanente Hawaii; Jackie Fernando, Operations Manager, Volunteer Services, Kaiser Permanente Hawaii; Kathy With a K, Host of "Hawaii Matters", Pacific Media Group; Brent Shimoda, 3rd year Medical Student, John A. Burns School of Medicine, University of Hawaii at Manoa[original radio broadcast: August 31, 2025]Pacific Media Group Oahu radio stations include 102.7 Da Bomb, 94.7 KUMU, HI93, and 105.9 The Wave.For "Hawaii Matters" inquiries, please email kathywithak@1059thewavefm.com

Episode: 1428 Why do men self-destruct and die sooner than women?  Today, men self-destruct.

As part of "The Lead" Jason talks with Associate Professor of Medicine from Northwestern University Feinberg School of Medicine Dr. Mark Sala about vaccines under attack, needing a prescription to get one, the change in distribution, stopping cancer research and more.

This hour Jason talks about vaccines under attack with Associate Professor of Medicine from Northwestern University Feinberg School of Medicine, he talks Twins with Dan Hayes from The Athletic, and we have DeRush Hour Headlines.

Twenty years ago, Hurricane Katrina made landfall in Louisiana, and the levees designed to protect New Orleans failed. Huge swaths of the city flooded, and 1,600 people were trapped inside Charity Hospital. Physician Erica Fisher was working in Charity's emergency room at the time, and she and her colleagues fought for days to keep their patients alive.Host Flora Lichtman speaks with Dr. Fisher, now an emergency medicine physician at University Medical Center in New Orleans, about Hurricane Katrina and the vulnerability of our healthcare systems in the face of disasters.Plus, science writer Maggie Koerth joins Flora to share other science news the week, including the link between heat waves and aging, updated COVID vaccine guidelines, the ancient origins of human mucus, and the possibility that dwarf planet Ceres could once have sustained life.Guest: Dr. Erica Fisher is an emergency medicine physician at University Medical Center in New Orleans, Louisiana.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Dr. Toni Engram is a biological dentist, integrative health coach, and owner of Flourish Dental Boutique in Richardson, TX. A fter her own personal health struggles with an autoimmune disease, Dr. Engram shifted her practice philosophy to focus on whole-body health, and the prevention and safer treatment of oral disease. She has degrees from Texas Christian University and Baylor College of Dentistry. Dr. Engram is a member of the IAOMT (International Academy of Oral Medicine and Toxicology) and the IABDM (International Academy for Biological Dentistry and Medicine). She is SMART certified in safe amalgam removal technique, accredited through the IAOMT, and is a TBI Ambassador through The Breathe Institute. She is also a certified Integrative Health Coach through the Institute of Integrative Nutrition. In this episode, Dr. Engram talks about the difference in approaches in traditional dentistry vs. biological dentistry, and how to eat and supplement to optimize your oral health!     RESOURCES: Learn more about Dr. Engram here: http://www.flourish.dental/ Instagram: @drtoniengram Get 15% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 0:00 Intro 3:30 How biological dentistry is different 8:30 Fluoride free toothpaste 12:15 Mercury amalgams 18:50 Dr. Engram's personal healing journey 24:00 Link between periodontal and heart diseases 30:35 How to fight decay 36:10 Weston A. Price's dental research in native communities 44:00 Insurance issues   WORK WITH ME: Are You Looking for Help on Your Wellness Journey? Here's how I can help you: TRY COACH TARA APP FOR FREE: http://taragarrison.com/app LEVEL UP PROGRAM: http://taragarrison.com/level-up INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the ‘Ratings & Reviews' section. Tap ‘Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

This year is the 50th anniversary of the first transcatheter ASD closure in a human. To celebrate this achievement, this week we air a live interview from PICS 2025 in Chicago (conducted 8/26/25) with living interventional cardiology legend Dr. Terry King speaking about the events surrounding his landmark intervention as the first person to ever perform a transcatheter ASD closure with his partner, surgeon Dr. Noel Mills. In this one on one interview, Dr. King discusses how he came up with this idea with Dr. Mills and how he found a patient in which to proceed. He reviews what 'informed consent' was in 1975 and also how he and Dr. Mills accurately estimated ASD size in an era that preceded 2D echocardiography. Dr. King speaks about the role of family in his life and offers advice to the next generation. Finally, he shares with us what he is up to today and why he does not believe in retirement. Prepare to be excited and inspired by this wonderful figure in our field. 

The psychedelic revolutionWill LSD, Psilocybin, MDMA, and Ketamine treatments live up to the hype?For decades, psychedelics were derided as dangerous recreational drugs; now many claim they have the potential to revolutionise the treatment of mental health. With hundreds of clinical trials now taking place, the psychedelic therapeutic market is predicted to be over ten billion within the decade. It has been widely thought that psychedelics are effective at treating mental health because of the way they change brain chemistry. But studies from King's College London and Johns Hopkins suggest this is an error, arguing that it's the psychedelic experience that aids mental wellbeing, not the physical brain changes.Should we stop focussing on brain chemistry as the solution to mental health? What is it about psychedelic experience that can aid mental well being and will psychedelics live up to their promise and usher in a mental health renaissance? Or is the hype bubble about to burst and should we look elsewhere for the silver bullet to the mental health crisis of our age?Matthew Johnson is Professor of Psychiatry and Behavioural Sciences at Johns Hopkins University. Shayla Love is a freelance reporter and former senior science writer at Vice News, focusing on psychedelics. Kevin Sabet is the founder of Smart Approaches to Marijuana, and he has been described as the "quarterback of the new anti-drug movement".Don't hesitate to email us at podcast@iai.tv with your thoughts or questions on the episode!To witness such debates live buy tickets for our upcoming festival: https://howthelightgetsin.org/festivals/And visit our website for many more articles, videos, and podcasts like this one: https://iai.tv/You can find everything we referenced here: https://linktr.ee/philosophyforourtimesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this riveting episode, Dr. Nelson Vazquez shares his extraordinary journey from a 325-pound diabetic on seven medications and 300 units of insulin a day—to a vibrant, medication-free advocate for carnivore nutrition and metabolic healing. After surviving a stroke and facing macular edema, Dr. Vazquez turned to ancestral eating, eliminating plant toxins and ultra-processed foods to reclaim his health and vitality.He and Dr. Kiltz dive deep into the failures of modern medicine, the dangers of dietary dogma, and the spiritual and emotional clarity that comes with radical lifestyle change. With humor, humility, and decades of clinical insight, Dr. Vazquez challenges everything we think we know about nutrition, disease, and healing.

Nutritionist Leyla Muedin discusses the critical role of mitochondrial health throughout the lifespan, citing Dr. Jeffrey Bland's insights on mitochondria as a cornerstone of 21st-century health. The episode explores the benefits of ketosis and the ketogenic diet, particularly in supporting neurological health and conditions like epilepsy, Alzheimer's, and multiple sclerosis. Leyla highlights how ketogenic diets stimulate mitochondrial biogenesis and improve mitochondrial function while addressing potential contraindications for specific populations. The importance of a functional medicine approach and personalized interventions is emphasized for optimal health outcomes.

In this episode, Kyle Glass, Regional CFO at UChicago Medicine AdventHealth, shares his perspective on key healthcare trends including Medicaid reform, outpatient growth, and AI-driven efficiency. He also highlights the impact of the UChicago partnership and offers thoughtful advice for rising healthcare leaders.

Send us a textThe potential link between acetaminophen (Tylenol) and autism, with a surprise phone call from RFK partway through.Episode Summary: Dr. William Parker talks about autism spectrum disorder (ASD), its rising prevalence since the 1980s, and the controversial hypothesis that acetaminophen exposure in susceptible infants and children triggers most cases via oxidative stress. They discuss ASD's clinical definition; historical misconceptions like the "refrigerator mother" theory; genetic susceptibilities; acetaminophen's metabolism, which produces toxic byproducts in underdeveloped livers, leading to brain effects.About the guest: William Parker, PhD spent nearly 30 years as a professor at Duke University researching underlying causes of chronic conditions, including discovering the immune function of the human appendix and pioneering studies on immune systems in wild animals.Discussion Points:Autism is a spectrum disorder with core symptoms like social deficits, repetitive behaviors, and aversion to new stimuli.Parker argues overwhelming evidence points to acetaminophen as the primary trigger in susceptible individuals, causing oxidative stress via toxic metabolite NAPQI.Acetaminophen, marketed as Tylenol or paracetamol, was not tested for neurodevelopmental effects in neonatal animals until 2014, despite widespread use since 1886; it's metabolized differently in babies, whose livers lack mature detox pathways.Susceptibility factors include low glutathione (an antioxidant), poor sulfation/glucuronidation metabolism, folate receptor autoantibodies, and events like immune reactions that prompt acetaminophen use during oxidative stress.Regressive autism, where children lose milestones after seeming normal, often follows acetaminophen given for fevers or illnesses, explaining parental vaccine suspicions (as shots coincide with drug use).Adult acetaminophen is generally safe but causes liver toxicity in overdoses or with alcohol; antidote is NAC to boost glutathione.Parker has suggested to policymakers that we should avoid acetaminophen during pregnancy, birth, and early childhood (under age 3-5); parents should plan ahead for fevers/pain without it, but seek medical help for unusual symptoms.*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Tenshin Fletcher Roshi talks about case 87 of the Blue Cliff Record, "Medicine and Disease."

Episode 201: AKI Roadmap.  Future Dr. Ayyagari describes the different types of acute kidney injury and shares some elements of management for each category. Dr. Arreaza shares some input about statistics and the importance of drinking water during summer.Written by Tejasvi Ayyagari, MSIV, Ross University School of Medicine. Edits and comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.INTRODUCTION:Dr. Arreaza: Hello everyone, and welcome back to Rio Bravo qWeek — your weekly dose of knowledge. I'm Dr. Arreaza, I am a faculty member and associate program director of the Rio Bravo FM residency program. In Episode 126, we briefly introduced the topic of Acute Kidney Injury (AKI), but today, we're taking a deep dive into the matter. I have here alongside my cohost, future Dr. Ayyagari, AKA TJ. Please, TJ, introduce yourself.TJ: Hey everyone, good to be back on the podcast. My name is TJ Ayyagari, and I am currently finishing my last rotation of medical school with Rio Bravo CSV outpatient.  I hope everyone is doing well and staying safe.Dr. Arreaza: So, TJ prepared this discussion about acute kidney injury, also known as AKI. This is a critical topic for our Kern community, especially during the summer months when the risk of AKI increases. You will face many patients with AKI on the wards, in the clinic, and especially on your future board exam. Hopefully, by the end of this episode, you all will have more information on AKI, but also the three different types: prerenal, intrinsic, and postrenal. TJ: Without further ado, let's get started, Dr. Arreaza.SECTION 1 – What is AKI?Dr Arreaza: Let's start with the definition. Let's explain what AKI is. TJ: Absolutely.  So, an AKI is not just a bump in the patient's creatinine. According to the Kidney Disease Improving Global Outcomes (KDIGO) definition, an AKI embodies any of the following criteria:Increase in serum creatinine by ≥0.3 mg/dL within 48 hours, ORIncrease in serum creatinine to ≥1.5 times baseline within the prior 7 days, ORUrine volume 20:1).  There is also a lab value called the Fractional excretion of sodium, otherwise known as FeNa, which will appear as 20:1 — looks like prerenal.FeNa 500 mOsm/kg.In the later phase (after prolonged obstruction → tubular injury):BUN: Cr ratio ~10–15:1 — now looks intrinsic.FeNa >2%.Urine osmolality ~300 mOsm/kg.Dr. Arreaza: BUN:Cr ratio and FeNa are not reliable to diagnose postrenal AKI, so we must rely more in imaging and clinical presentation. Let´s talk about the management of postrenal AKI.TJ: Absolutely!  The main way to treat a post-renal AKI is to relieve the obstruction causing it in the first place, whether it be through surgery, TURP, lithotripsy, etc.Dr. Arreaza: I think the favorite treatment done by urology to relieve obstruction is a ureteral stent, which, remember, needs to be removed later. Typically, 1-2 weeks is sufficient to treat kidney stones. The risk of encrustation and infection increases significantly after 4–6 weeks, and stents should ideally be exchanged within 3 months to minimize complications. SECTION 5 – ClosingDr. Arreaza: I know you've spent a decent amount of time explaining the details of the AKI types with us, TJ, but could you give us a summary?TJ: Viewers, if there's anything to take away from this, remember:Prerenal: Poor perfusion, fix the flow.Intrinsic: Structural damage inside the kidney — think ATN, AIN, GN.Postrenal: Obstruction — relieve the blockage.When you see AKI, think: Before the kidney, in the kidney, or after the kidney? That simple framework can help you move fast and help your patient recover kidney function.Dr. Arreaza, any advice you want to give to the viewers?Dr. Arreaza: Yes,weare in the middle of summer, and we treat a large amount of farm workers, construction workers and people who spend time outdoors, in general, remind your patients to drink water. Water is life, especially for the kidneys, there is no substitute. That's it for today's episode of Rio Bravo qWeek. If you enjoyed this review, share it with a colleague or medical student who could use a quick AKI refresher. And remember — the kidneys may be small, but they're mighty… and they hold grudges when you ignore them. I'm Dr. Arreaza, signing off.TJ: Thank you for tuning in, everyone. Have a nice day!Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012;2:1–13. https://kdigo.org/guidelines/acute-kidney-injury/.Kaur A, Sharma GS, Kumbala DR. Acute kidney injury in diabetic patients: A narrative review. Medicine (Baltimore). 2023 May 26;102(21):e33888. doi: 10.1097/MD.0000000000033888. PMID: 37233407; PMCID: PMC10219694. https://pmc.ncbi.nlm.nih.gov/articles/PMC10219694/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

In this episode of "Research Ethics Reimagined," we explore human challenge studies for shigellosis, examining their role in vaccine development and the ethical considerations surrounding intentional infection of healthy volunteers. Our guests are Dr. Wilbur H. Chen, the Frank M. Calia, MD Endowed Professor and Chief of the Division of Geographic Medicine at the University of Maryland School of Medicine, and Jake Eberts of 1Day Sooner, who is a former participant in a Shigella challenge trial.

AI is showing up everywhere in medicine, from symptom checkers to lab summaries, and I often hear clinicians wonder where that leaves us.    In this episode, I share how I see technology as a helpful partner while holding firm to the truth that no algorithm can replace the trust, empathy, and presence our patients deserve. My own journey from burnout to building a practice rooted in connection has shown me that we carry a kind of medicine AI will never touch. Can a computer sit with someone in grief? Can it notice the subtle shift in tone or energy that tells you more than lab results ever could? I want you to think about how you bring your humanity into care, how you amplify the qualities that make your practice unique, and how AI might support rather than overshadow your role as a healer and entrepreneur.   Episode Breakdown: 00:00 AI in Healthcare and Human Connection   05:01 How Clinicians Use AI in Practice   07:06 The Limitations of AI in Medicine   09:30 Unique Human Abilities in Patient Care   13:02 Translating Science Into Soul-Aligned Action   16:14 Building a Human-Centered Practice   20:31 Celebrating Patient Wins and Progress   26:06 Catalyst Question: What AI Can't Do in Medicine     Links The Catalyst Studio   Episodes about AI: Episode 57: ChatGPT For Health and Wellness Content Marketing Episode 58: Providers Regaining Their Time and Sanity With the Help of Virtual Scribes and Virtual Assistants Episode 106: The Future of Charting With AI – Dr. Lara Salyer   Episodes about creating a welcoming atmosphere: Episode 46: Front Office Makeover With the Aha! Method Episode 104: Making Your Practice a Holistic Office   Connect with Lara:  Website The Catalyst Way YouTube Instagram  Facebook LinkedIn TikTok     Podcast production and show notes provided by HiveCast.fm

Children deserve the safest possible healthcare, yet they remain one of the most vulnerable patient populations when it comes to medicines safety. Ahead of World Patient Safety Day on 17 September, we discuss challenges and solutions in paediatric pharmacovigilance with ISoP president Angela Caro-Rojas.Tune in to find out:Why we need a Patient Safety DayHow to prevent common medication errors in childrenHow to build child-friendly healthcare environmentsWant to know more?Visit the World Health Organization's campaign website to learn more about World Patient Safety Day and download campaign materials.You can also show support for the campaign by joining ISoP's free virtual event on September 18 and 19, or visit ISoP's YouTube channel to access recordings from previous Patient Safety Day events.For more on paediatric pharmacovigilance and ISoP's activities, check out these episodes from the Drug Safety Matters archive:The KIDs ListWhat's trending in pharmacovigilance? Join the conversation on social mediaFollow us on Facebook, LinkedIn, X, or Bluesky and share your thoughts about the show with the hashtag #DrugSafetyMatters.Got a story to share?We're always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!About UMCRead more about Uppsala Monitoring Centre and how we promote safer use of medicines and vaccines for everyone everywhere.

Garry Nolan, PhD, is an immunologist and professor at Stanford University School of Medicine. He is also a business executive and Executive Director of the Board of the Sol Foundation, a research and advocacy center focused on UAP studies.  www.thesolfoundation.org Hunt with confidence using onX Hunt. Start your free trial today at: https://huntsmarter.smart.link/srwbpznr2 This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoices

⭐️Mentioned in This Episode:- See all the resources

Right up front here, let me just state loudly that there are some amazing independent TPAs (third-party administrators) out there who have the expertise, the scrappy willfulness, and the deep desire to do right by their clients, their self-insured employer clients. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. And look, they may be facing some of the same headwinds that plan sponsors themselves face, like anticompetitive contracts, brokers who are up to no good, etc. So, just keep that in mind as you listen. And the main point of all of this if you are a plan sponsor is, find a good TPA partner, which, as Bryce Platt has said about consultants but same rules apply about TPAs here, the difficulty is being informed enough to tell the difference. So, the goal of this show is to help with that, the “be informed enough to tell the difference.” All of this being said, this is technically a Take Two; but we trimmed it down and welcome to a whole new intro. So, call this a refresher and an update about a really, really important topic from last year that is becoming extremely (maybe even more) relevant this year. Really relevant. Consider, for example, the show with Claire Brockbank (EP453) about carrier/TPA RFPs (requests for proposal) and all of the landmines that are really expensive, that are buried in some of these contracts. Then there was the Cynthia Fisher show (EP457) from last year about the millions, maybe billions of dollars in aggregate going missing in medical (ie, TPA or ASO [administrative services only]) spread pricing. We had “The Mystery of the Weekly Claims Wire” show with Justin Leader (EP433), again, revealing money that's being disappeared when the TPA is withdrawing dollars from plan sponsor checking accounts. And then there's the payment integrity episode with Kimberly Carleson (EP480) from a few weeks ago with just another wrinkle on this, namely TPAs or ASOs who insist on auditing themselves and how that turns out for members and plan sponsors. Oh, and last, but certainly not least, is the whistleblower show with Ann Lewandowski (EP476) on how a TPA arm of an EBC (employee benefit consultant) allegedly pocketed $20 million—$20 million of their client's pharma rebates—and used that $20 million to fund their executive bonus pool. What a time to be alive! All of this just highlights the huge stakes for plan sponsors to really understand what their TPA is all about. And when I say high stakes, I mean from both a legal standpoint and also just vast dollars in play here. But this episode with Elizabeth Mitchell is also, I'm gonna say, extremely relevant given just a few ripped from the headlines and news articles such as these. I'm gonna start actually with a post from Kimberly Carleson, and I like the comment by Jeff Evans, who wrote, “How does $8,710 equal $104,266?” Spoiler alert, it doesn't. Lots of missing dollars there. Someone's hands are in the cookie jar. Oh, look, the TPA has entered the chat. In a nutshell, and I'm quoting something Peter Hayes wrote, he wrote, “TPAs have received relatively little public attention. [There's an article in Health Affairs] that describes how TPAs impose hidden fees, benefit from their own form of spread pricing, and otherwise prioritize their own financial interests over those of their plan clients.” Also, here's a totally other issue. Let me quote Luke Prettol highlighting something Jason Shafrin had written about a paper by Jeff Marr, Daniel Polsky, and Mark Meiselbach. Let me slightly rephrase what Luke said. He wrote, “Employers pay, on average, a 4.7% [so almost 5%] price markup when hospitals are in their TPA's [Medicare Advantage] network.” Right? Dr. Eric Bricker talked about this in that episode (EP472) just how TPAs with MA (Medicare Advantage) business negotiate their commercial clients to pay higher rates so that then they can pay lower rates for their own MA members. As Luke wrote, “On its face, this overpayment does not appear to be solely in the interest of participants.” No kidding. Now, let's spin the wheel here. There are barriers for TPAs themselves, even the ones who have a deep desire to do the right thing. As Patrick Moore wrote, “Most TPAs still can't do [many of the things that employers might want because there are] PPO contracts.” So, is it a rock in a hard place situation? I mean, if the TPA has no other options than using a carrier's PPO (preferred provider organization) network with all its attendant contractual issues, then yeah, that is one definite challenge. Along these lines, let me read a post by Rina Tikia, because I think she sums up this really well. “When independent TPAs … push for transparency, they're blocked under the banner of ‘fiduciary risk.' “Meanwhile, the largest carriers and PBMs, with Cayman shell subsidiaries, DOJ kickback probes, [huge] hedge fund ties, [$10 million-plus] lobbying budgets, and antitrust violations continue unchecked. They are not only allowed to operate but celebrated as mainstream options. “Why the double standard? Political donations? Foundation smokescreens? Nonprofit status as a PR shield?” These are excellent questions. And here's another challenge: brokers. Ramesh Kumar Budhani wrote about this one, just how hard it is sometimes to find—for TPA, an independent TPA, trying to do the right thing—to find brokers who prioritize doing the right thing for employers and helping their clients save money. The summary of all of this: There are TPAs and there are ASOs who aren't even trying. They are going to ride the flywheel, the gravy train, and catch all of the dollars flying off of it for as long as they can manage to cling to it with all 10 of their fingers. Then there are TPAs, mostly indies, trying super hard to do the right thing. But how successful they are is going to depend on how boxed in they are by the PPO networks or the carriers that the brokers or even plan sponsors may insist on. Just how courageous they are and just how smart they are and experienced they are about the market and how it actually operates. So, the show that follows is about all of this, including how we can inspire TPAs, which, in the show that follows, subsumes ASOs kind of into it. But in the show that follows, I hope it's inspiring to create an environment so that the market demands TPAs that do all of the things, and we make inertia not a viable business strategy. Elizabeth Mitchell, my guest today, currently serves as the president and CEO of the Purchaser Business Group on Health. Also mentioned in this episode are Purchaser Business Group on Health; Bryce Platt; Claire Brockbank; Cynthia Fisher; Justin Leader; Kimberly Carleson; Ann Lewandowski; Jeff Evans; Peter Hayes; Luke Prettol; Jason Shafrin; Jeff Marr; Daniel Polsky; Mark Meiselbach; Eric Bricker, MD; Tom Nash; Patrick Moore; Rina Tikia; Ramesh Kumar Budhani; Mark Cuban; Harold Miller; Chris Deacon; Moby Parsons, MD; Benjamin Schwartz, MD, MBA; Mishe Health; Rik Renard; and Cora Opsahl. You can learn more at PBGH and by connecting with Elizabeth on LinkedIn.   Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health (PBGH), advances its strategic focus areas of advanced primary care, functional markets, and purchasing value. She leads PBGH in mobilizing health care purchasers, elevating the role and impact of primary care, and creating functional healthcare markets to support high-quality affordable care, achieving measurable impacts on outcomes and affordability. At PBGH, Elizabeth leverages her extensive experience in working with healthcare purchasers, providers, policymakers, and payers to improve healthcare quality and cost. She previously served as senior vice president for healthcare and community health transformation at Blue Shield of California, during which time she designed Blue Shield's strategy for transforming practice, payment, and community health. Elizabeth served as the president and CEO of the Network for Regional Healthcare Improvement (NRHI), a network of regional quality improvement and measurement organizations. She also served as CEO of Maine's business coalition on health (the Maine Health Management Coalition), worked within an integrated delivery system (MaineHealth), and was elected to the Maine State Legislature, serving as a State Representative. Elizabeth served as vice chairperson of the U.S. Department of Health and Human Services Physician-Focused Payment Model Technical Advisory Committee, board and executive committee member of the National Quality Forum (NQF), member of the National Academy of Medicine's “Vital Signs” Study Committee on core metrics, and a guiding committee member for the Health Care Payment Learning & Action Network. Elizabeth holds a degree in religion from Reed College and studied social policy at the London School of Economics.   08:06 What is the overarching context for health plans in healthcare purchasing? 11:31 Why is it important to reestablish a connection between the people paying for care and people providing care? 13:47 What are the needs of a self-insured employer when managing employee benefits? 19:00 Is it doable for employers to set their own contracts? 21:24 Is transparency presumed? 22:39 Will the new transparency upon us actually expose wasted expense? 24:23 EP408 with Chris Deacon. 25:58 “This is not about individual bad actors. … The systems … that is not aligned.” 27:39 Are there providers who want to work directly with employers? 30:53 Why is it important that incentives need to be aligned? 32:42 EP427 with Rik Renard. 33:51 What's missing from the conversation on changing health plans?   You can learn more at PBGH and by connecting with Elizabeth on LinkedIn.   @lizzymitch2 of @PBGHealth discusses #TPA and #healthplan vs. #jumboemployer inertia on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts)  

Medicine isn't fair, and often it sets us up for burnout in ways we don't even realize. So what do we do when the system is rigged against us? Let's dive in to how we overcome that while also avoiding burnout. Join me for my FREE course: coach-miles.com/secret

How much leucine should I take to regain muscle?Should I increase my creatine dose to 10 grams daily for the cognitive benefits?You talked about the cancer risk of CT scans. What about CT angiograms?  I've had a ganglion cyst drained twice. How can I keep it from coming back?Who can I contact for treatment of mast cell activation syndrome?I heard you should brush your teeth with fluoride toothpaste if there's no fluoride in your drinking water 

How reliable is nutrition science?I have gingivitis, and my dentist recommended Listerine. Won't that disrupt the microbiome in my mouth?I take a diuretic for high blood pressure. Is it okay to stop drinking water by 8pm, or will I dehydrate?Is there a way to get rid of seborrheic keratoses?

The concept of Food as Medicine has been central to Biological Soil Management, drawing a clear connection between human health and turf health. Just as proper nutrition helps our bodies build natural immunity and resist disease, balanced fertility programs help turf recover from stress, develop stronger roots, and support healthy soil biology.In this episode, we revisit one of Jerry's lectures given over a decade ago in Australia, where he discusses the importance of nutrition for long-term health. While his focus here is on human health, he often highlights the parallels to plant health and the role of nutrition in building resilience.At EarthWorks, this philosophy continues to guide our fertility approach, with natural products like Replenish fertilizers and CalVantage designed to build healthy soils and stronger turf.Visit EarthWorks at:  https://www.earthworksturf.com Podcasts: https://www.earthworksturf.com/earthworks-podcasts/ 2 Minute Turf Talks: https://www.earthworksturf.com/2-minute-turf-talks/

(00:00) Path to Medicine and Representation(10:45) Navigating Challenges in Pre-Med Studies(17:10) Navigating Learning Differences and Accommodations(29:09) Journey to Medical School Acceptance(35:27) Perseverance in the Journey to MedicineAt 17, Katya's life took an unexpected turn when a spark for dermatology lit up her path away from fashion. Join us as Katya shares her unique journey through the world of medicine, a path filled with challenges, self-discovery, and unyielding determination. Hear how her mother's insight into the demand for dermatologists and the experience of shadowing a physician of color solidified her commitment to a field where representation and cultural competence are crucial. Katya's story sheds light on the underrepresentation of Latino physicians in the U.S. and highlights the vital role of family and community support in overcoming self-doubt.The academic journey wasn't smooth sailing for Katya, who faced hurdles at Princeton that tested her resolve. Discover how initial setbacks and lower-than-expected grades fueled her imposter syndrome, propelling her to reevaluate her approach to premed studies. Through strategically pausing her coursework and immersing herself in diverse academic experiences abroad, Katya not only enhanced her college journey but also prepared for future medical school applications. Her candid discussion reveals the power of friendships, therapy, and core values in navigating the demanding world of premed, and serves as a guide for those facing similar battles.Listen as Katya recounts the emotionally charged process of medical school applications, drawing parallels to the unpredictability of dating. From receiving just one interview invite to the thrill of an acceptance call from Stanford on her birthday, her journey is a testament to perseverance against all odds. Katya opens up about learning differences and the significance of accommodations, breaking down the stigma and proving that success is within reach for those who seek the support they need. Her story is a beacon of hope for aspiring medical students, reinforcing that with grit and determination, even the most formidable barriers can be overcome.

On this episode, we define obsessive-compulsive disorder (OCD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing OCD, including pharmacologic and non-pharmacologic interventions. We also, compare and contrast the efficacy, safety profiles, and appropriate use of selective serotonin reuptake inhibitors (SSRIs), cognitive behavioral therapy (CBT), and other emerging treatment modalities for OCD.  Dr. David Osser's psychopharmacology Algorithm Website  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

In this powerful episode, we sit down with Christa Black, a former Christian recording artist who toured with Michael W. Smith and the Jonas Brothers for over a decade. Christa shares her shocking journey from representing the global bride of Christ at "The Call" stadium event to losing everything in Costa Rica through plant medicine ceremonies.After years as a successful Christian author and speaker, Christa found herself drawn into the New Age world through seemingly innocent concepts like manifestation and energy healing. What began with small compromises eventually led to ayahuasca and wachuma ceremonies, where she encountered false spirits, including a being claiming to be Satan who asked her to "advocate for him before the Father."Christa reveals the sophisticated deception tactics of the enemy, how plant medicine creates spiritual "loans" that must eventually be repaid, and the legal authority given to dark entities through these practices. She explains the difference between legitimate spiritual gifts and their New Age counterfeits, and how fallen angel technology has been downloaded through indigenous plant ceremonies.Most importantly, Christa shares her dramatic rescue story - how God orchestrated her return to faith through a 16-year-old bracelet and the very songs from her wedding day. Now back in relationship with Jesus, she uses her authority from having been "in their camps" to pray for others trapped in deception.This episode serves as both a warning about the growing mainstream acceptance of psychedelics and a testimony of God's relentless pursuit of His people, no matter how far they've fallen. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this inspiring episode of American Potential, host David From speaks with Dr. Chaminie Wheeler, a pediatrician who walked away from the traditional hospital system to launch a direct primary care (DPC) practice—putting patients, not paperwork, at the center of healthcare. Raised in a small village in Sri Lanka, Dr. Wheeler's passion for helping others began at a young age and followed her to Pennsylvania, where she built CCC Health from the ground up with help from the Tax Cuts and Jobs Act. She shares how the broken insurance-based model shackled her ability to treat patients with compassion and clarity. From unnecessary CT scans to delayed diagnoses, Dr. Wheeler reveals how bureaucracy often prevents real healing—and why DPC offers a better way forward. This episode dives deep into the challenges independent doctors face, the critical role of expanded Health Savings Accounts (HSAs), and how innovation thrives when government steps back. Dr. Wheeler's story is a reminder that when we trust doctors and empower patients, we unlock the real potential of American healthcare.